Article

Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Topic: Business OpportunitiesPublished April 27, 2023

Legacy signals

Legacy popularity: 300 legacy views

Alfa Chemistry, a leading pharmaceutical supplier, has recently announced the addition of three new APIs to its full-ranged product catalog, i.e., tofacitinib citrate, tamoxifen citrate, and epalrestat. These new products are introduced to meet the growing demands of the pharmaceutical market. Tofacitinib CitraternTofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by suppressing the immune system and reducing inflammation in the body. Tofacitinib Citrate is a selective inhibitor of Janus kinase (JAK) enzymes, which play a key role in immune response and inflammatory signaling. Alfa Chemistry offers tofacitinib citrate as active pharmaceutical ingredients in various purities and quantities to meet the specific requirements of different research projects. The product is manufactured using advanced technology and under strict quality control procedures to ensure its safety and effectiveness. Tamoxifen CitraternTamoxifen Citrate is a medication used to treat breast cancer and prevent its recurrence. It works by blocking the effects of estrogen on breast tissue, which can promote the growth of cancer cells. Tamoxifen Citrate is also used for some other medical purposes. Alfa Chemistry offers tamoxifen citrate as active pharmaceutical ingredients in various purities and quantities to meet the specific needs of different research projects. Like all other chemicals provided by Alfa Chemistry, this product is also manufactured using advanced technology and under strict quality control procedures to ensure its safety and effectiveness. EpalrestatrnEpalrestat is used to treat diabetic neuropathy, a condition that affects millions of people worldwide. By providing high-quality epalrestat as active pharmaceutical ingredients, Alfa Chemistry is supporting the development of better treatments for this condition and helping to improve the quality of life for people living with diabetes. “Researchers and pharmaceutical companies can now turn to us for high-quality APIs to help advance the treatment of various medical conditions. With innovative solutions and excellent customer service, Alfa Chemistry is well-positioned to become a leading supplier in the pharmaceutical industry,” commented the Marketing Chief of Alfa Chemistry. For more information, please visit https://alfa-api.com/ or email us directly.

Further reading

Further Reading

4 total

Article

India’s infrastructure growth has accelerated significantly over the past two decades. From expanding highways and railway networks to large-scale urban development and industrial corridors, the backbone of these projects is steel. Steel manufacturing plays a vital role in enabling the country to build durable structures, modern transportation systems, and energy facilities that support economic progress. The availability of specialized steel grades and precision-manufactur

March 10, 2026

Article

Modern life moves quickly, and managing daily responsibilities alongside professional commitments can often feel overwhelming. This is where concierge services come into play. Designed to simplify life and provide personalized support, concierge services have become increasingly popular among professionals, businesses, and families who value convenience, efficiency, and premium lifestyle support. From handling routine errands to organizing exclusive experiences, concierge ser

March 6, 2026

Article

Introduction The world of healthcare often leaves behind unused items, and diabetic supplies are among them. Many people find themselves with extra test strips, lancets, or glucose meters due to changes in prescriptions, insurance coverage, or simply overstocking. This situation raises a natural question: how much money can someone make by selling these supplies? While the answer varies, the journey of understanding this market reveals both opportunities and limitations. The

March 3, 2026

Article

The Evolution of the Doorstep Handshake In the early days of the renewable energy boom, the transition to solar power was often viewed as a purely transactional event. Homeowners saw panels on a roof, signed a contract, and hoped for the best. However, as the industry matured, the focus shifted from the hardware itself to the human connection that precedes the installation. This shift has turned a simple meeting into a cornerstone of business growth. The journey toward a sust

February 18, 2026